Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -130,302 | -101,744 | -108,176 | -58,235 | -51,972 |
| Depreciation Amortization | -2,118 | -979 | 1,608 | 897 | 718 |
| Accounts receivable | N/A | 2,000 | N/A | N/A | -2,000 |
| Accounts payable and accrued liabilities | -1,184 | -1,705 | 1,097 | 1,232 | 1,171 |
| Other Working Capital | -31,746 | -37,966 | -18,493 | -11,345 | 118,674 |
| Other Operating Activity | 33,849 | 22,412 | 14,884 | 7,924 | 3,483 |
| Operating Cash Flow | $-131,501 | $-117,982 | $-109,080 | $-59,527 | $70,074 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -754 | -1,526 | -7,692 | -1,837 | -1,106 |
| Purchase Of Investment | -240,888 | -310,574 | -208,504 | -372,361 | -207,540 |
| Sale Of Investment | 327,768 | 353,526 | 242,595 | 190,764 | 63,220 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -40 |
| Investing Cash Flow | $86,126 | $41,426 | $26,399 | $-183,434 | $-145,466 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 47,664 | 81,958 | 1,623 | 1,058 | 40 |
| Other Financing Activity | 0 | 448 | -8 | 356,267 | 80,844 |
| Financing Cash Flow | $47,664 | $82,406 | $1,615 | $357,325 | $80,884 |
| Beginning Cash Position | 69,808 | 63,958 | 145,024 | 30,660 | 25,168 |
| End Cash Position | 72,097 | 69,808 | 63,958 | 145,024 | 30,660 |
| Net Cash Flow | $2,289 | $5,850 | $-81,066 | $114,364 | $5,492 |
| Free Cash Flow | |||||
| Operating Cash Flow | -131,501 | -117,982 | -109,080 | -59,527 | 70,074 |
| Capital Expenditure | -754 | -1,526 | -7,692 | -1,837 | -1,106 |
| Free Cash Flow | -132,255 | -119,508 | -116,772 | -61,364 | 68,968 |